Pathogenesis and inflammaging in MDS [MDS Professional Report]
Feb 1, 2025 - 28:47
Radio and PodcastLive Radio & Podcasts![MDS in ASH 2021 – Are we already in the molecular era? [MDS Professional Report] artwork](https://d3wo5wojvuv7l.cloudfront.net/t_rss_itunes_square_1400/images.spreaker.com/original/6f4d6f2e2159220a3406f67f0e6f82f9.jpg)
Health
MDS in ASH 2021 – Are we already in the molecular era? [MDS Professional Report]
Drs. Moshe Mittelman, of The Tel Aviv Sourasky Medical Center, and Drorit Merkel, of the Sheba Medical Center, both from Tel Aviv University, Israel, discuss several important presentations from the recent 2021 ASH meeti...
About This Episode
MDS in ASH 2021 – Are we already in the molecular era? [MDS Professional Report] is an episode from MDS Professional Report by PI Media. Drs. Moshe Mittelman, of The Tel Aviv Sourasky Medical Center, and Drorit Merkel, of the Sheba Medical...
Podcast
This episode belongs to MDS Professional Report.
Listen Online
Use the player on this page to stream the episode online.
Episode Details
Published Feb 6, 2022, 36:12 long, audio available.
Related Episodes
Continue listening to more episodes from MDS Professional Report.
Treatment of lower-risk MDS [MDS Professional Report]
Dec 15, 2024 - 28:57
Treatment for Higher-risk MDS [MDS Professional Report]
Dec 1, 2024 - 28:49
Update on Higher-Risk MDS - Lessons from 2023 ASH [MDS Professional Report]
May 27, 2024 - 21:49
New trials to address the anemia of lower-risk MDS [MDS Professional Report]
Mar 27, 2024 - 27:58
Transfusions and quality of life [MDS Professional Report]
May 1, 2023 - 21:49
Bone marrow failure disorders in childhood [MDS Professional Report]
Dec 5, 2022 - 22:31
The role of genetics in MDS management [MDS Professional Report]
Sep 28, 2022 - 22:02
Questions About This Episode
What is MDS in ASH 2021 – Are we already in the molecular era? [MDS Professional Report] about?
Drs. Moshe Mittelman, of The Tel Aviv Sourasky Medical Center, and Drorit Merkel, of the Sheba Medical Center, both from Tel Aviv University, Israel, discuss several important presentations from the recent 2021 ASH meeting. They focus on the new IPSS-M classification, discuss the approach to the MDS patient who is currently defined by IPSS/R as belonging to the /lower- risk group but in fact the disease behaves like a higher-risk. Finally, they discuss issues regarding the treatment of patients with HR-MDS: What can be added to hypomethylating agents ? Targeted therapy with IDH1/2 inhibition and more…
Where can I listen to MDS in ASH 2021 – Are we already in the molecular era? [MDS Professional Report]?
You can listen to MDS in ASH 2021 – Are we already in the molecular era? [MDS Professional Report] online on Radio and Podcast. Open the player on this page to stream the available audio.
Which podcast is MDS in ASH 2021 – Are we already in the molecular era? [MDS Professional Report] from?
MDS in ASH 2021 – Are we already in the molecular era? [MDS Professional Report] is an episode from MDS Professional Report by PI Media.
How long is this episode?
This episode is 36:12 long.
When was this episode published?
This episode was published on Feb 6, 2022.
Can I save MDS in ASH 2021 – Are we already in the molecular era? [MDS Professional Report] for later?
Yes. Use the heart button on the episode page to add it to your favorite episodes list.
Are there related episodes from MDS Professional Report?
Yes. This page shows related episodes from MDS Professional Report when more episodes are available from the podcast feed.
Quick Answers About This Episode
Where can I listen to MDS in ASH 2021 – Are we already in the molecular era? [MDS Professional Report]?
You can listen to MDS in ASH 2021 – Are we already in the molecular era? [MDS Professional Report] on this page when the episode audio is available from the podcast feed.
Which podcast is this episode from?
MDS in ASH 2021 – Are we already in the molecular era? [MDS Professional Report] is from MDS Professional Report by PI Media.
What are the episode details?
Published Feb 6, 2022 and 36:12 long